Hmo

Chr. Hansen and Nestlé settle HMO patent litigation

Chr. Hansen and Nestlé settle HMO patent litigation

By Will Chu

Chr. Hansen and Nestlé have settled a legal dispute involving alleged infringements on Human Milk Oligosaccharide (HMO) patents arising from October 2020’s acquisition of Jennewein Biotechnologie.

Getty Images

DSM delves into structural diversity of HMOs

By Lynda Searby

DSM is hoping to shed new light on optimum HMO (Human Milk Oligosaccharide) combinations by furthering scientific knowledge around their structural diversity.

© JONGHO SHIN / Getty Images

Gut simulation expands health benefits of HMOs in adults

By Stephen Daniells

The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.

© robertprzybysz / Getty Images

Probiotics help preterm babies establish a 'normal' microbiome: Study

By Danielle Masterson

Specific strains of probiotic Bifidobacterium and Lactobacillus bacteria given to preterm babies in combination with breast milk may help to build microbial populations and gut health that mirror those of full-term babies, suggests data from the Baby-Associated...

HMO milk concentrations linked to baby growth at age five

Editor's Spotlight

HMO milk concentrations linked to baby growth at age five

By Nathan Gray

The concentrations of specific human milk oligosaccharides (HMOs) in breast milk have a significant impact on growth in early childhood, and later risk of obesity, say researchers - adding that findings may inform product development and therapeutic opportunities...

© Getty Images / TLFurrer

BASF joins the HMO club with 2’-FL launch

By Stephen Daniells

Human milk oligosaccharides (HMOs) are the “hot new thing” said an expert recently, as BASF announced the US launch of its 2’-FL (2’-fucosyllactose) ingredient, which is branded Prebilac.

©iStock/Pilin_Petunyia

DuPont study highlights HMO’s benefit on infant gut health

By Will Chu

A DuPont-led study outlines 2’-fucosyllactose’s (2’-FL) beneficial effect on the infant gut compared to galacto-oligosaccharides (GOS) and lactose as a team identify the oligosaccharide as a first choice energy source for selected infant microbes.

Jennewein Biotechnologie is building one of the largest fermentation plants in Central Europe. Pic: ©Getty Images/magone

Jennewein Biotechnologie and Yili join forces in HMO research

By Jim Cornall

Jennewein Biotechnologie GmbH, a German company involved in the research and manufacture of human milk oligosaccharides (HMO), and Inner Mongolia Yili Industrial Group (Yili Group), China’s leading dairy company, have signed a Memorandum of Understanding...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers